← Leaderboards
Joe R Delaney
Medical University Of South Carolina
$3,839,678
Attributed
$3,915,178
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,915,178 · 6
By mechanism
DP2$2,265,000 · 1
R00$729,675 · 1
R21$388,256 · 1
R03$301,854 · 2
K99$230,393 · 1
Top collaborators
- Christina Voelkel-Johnson1 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Besim Ogretmen$19,638,711
- Dieter Haemmerich$4,432,514
- Natalia Ivanovna Krupenko$2,526,008
- Narayan R Bhat$5,057,283
- Christina Voelkel-Johnson$2,967,908
Others in their field
Other Emerging Leaders on “Genetic”
- Leonard Freedman · Leidos Biomedical Research, Inc.$89,060,933
- Ted Ross · University Of Georgia$68,763,143
- Scott Topper · Broad Institute, Inc.$64,989,588
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Dale Sandler · Social And Scientific Systems, Inc.$43,209,852
Research focus
GeneticMalignant NeoplasmsCellsSerousTumorMalignant Neoplasm Of OvaryMolecularAneuploidyGenesOncogenesIn VivoTp53 GeneEventMouse ModelAutophagocytosisChloroquineRecyclingInvestigationBioinformaticsCohortPathway InteractionsGenomicsDrug TargetingCancer Type
Grant awards (11)
Tumor suppressor vulnerability conferred by aneuploid loss of haploinsufficient metallothionein genes$906,000
DP2 · FY2025 · CA · contact PI
Biologic rationale of fallopian tube removal to prevent uterine serous carcinoma$388,256
R21 · FY2025 · CA · contact PI
Identification of essential biomarkers in the polyploid cancer cell lifecycle$151,000
R03 · FY2024 · CA
Combination Of Autophagy Selective Therapeutics (COAST) in Serous Ovarian Cancer$75,500
R03 · FY2023 · CA · contact PI
Tumor suppressor vulnerability conferred by aneuploid loss of haploinsufficient metallothionein genes$1,359,000
DP2 · FY2022 · CA · contact PI
Combination Of Autophagy Selective Therapeutics (COAST) in Serous Ovarian Cancer$75,354
R03 · FY2022 · CA · contact PI
Copy Number Alterations in Low Mutation Cancer$246,525
R00 · FY2021 · CA · contact PI
Copy Number Alterations in Low Mutation Cancer$246,525
R00 · FY2020 · CA · contact PI
Copy Number Alterations in Low Mutation Cancer$236,625
R00 · FY2019 · CA · contact PI
Copy Number Alterations in Low Mutation Cancer$111,497
K99 · FY2018 · CA · contact PI
Copy Number Alterations in Low Mutation Cancer$118,896
K99 · FY2017 · CA · contact PI